X-group (possible homology)

4945 C-terminal a+b domain in Poly(A) polymerase catalytic subunit

Ligands and drugs

9
Member domains
4
with ligand contacts (≤ 4 Å)
44.4% of members
3
with DrugDomain annotations
33.3% of members
3
with a DrugBank compound
33.3% of members

Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.

Chemical profile

ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.

1
Proteins with classified ligands
1
Superclasses bound (of 23)
—
Superclasses per 20 proteins
fewer than 20 proteins: too few to compare at equal depth

The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.

SuperclassProteinsExpected
0.25×observed / expected4×
RatioSignificance
Nucleosides, nucleotides, and analogues10.33.67×not tested
enriched (q < 0.05)depleted (q < 0.05)not significantnot tested (expected < 5)

Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.

DrugBank compounds

DrugBankPDB ligandNameDomains
DB018603ATCordycepin Triphosphate3
DB03685U5PUridine monophosphate2

Most frequently bound compounds

PDB ligandNameDomains in contact
3AT3'-DEOXYADENOSINE-5'-TRIPHOSPHATE3
AGSPHOSPHOTHIOPHOSPHORIC ACID-ADENYLATE ESTER1